Reported results
- Recognized $2.0 million of license fee revenue during the third quarter of 2026, compared to $0 in the third quarter of 2025.
- Research and development expenses were $26.0 million for the third quarter of 2026, compared to $28.5 million for the third quarter of 2025.
- General and administrative expenses were $7.8 million during the third quarter of 2026, compared to $5.3 million during the third quarter of 2025.
- Total other expense was $7.0 million during the third quarter of 2026, compared to $1.4 million during the third quarter of 2025.
- Net loss was $38.7 million, or $2.46 per basic and diluted share, during the third quarter of 2026, compared to a net loss of $35.3 million, or $2.28 per basic and diluted share, during the third quarter of 2025.
- Cash and cash equivalents were $199.5 million as of September 30, 2026.
Price and volatility reaction
The stock moved -6.8% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +11.4 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 83.3 | 2026-11-13 |
| Close after release | 77.66 | 2026-11-16 |
| Realised move | -6.8% | close to close |
| 30d ATM IV change | +11.4 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-13 (8-K, Item 2.02). Read the original filing on sec.gov.
